Press Release-99-040, Nuclear Regulatory Commission'S Advisory Committee on Medical Use of Isotopes Has Scheduled Meetings March 24-25 in Rockville, Maryland: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
 
(Created page by program invented by StriderTol)
Line 1: Line 1:
#REDIRECT [[Press Release-99-040, Nuclear Regulatory Commission'S Advisory Committee on Medical Use of Isotopes Has Scheduled Meetings March 24-25 in Rockville, Maryland, Press Release-99-040, Nuclear Regulatory Commission'S Advisory Committee on Medical Use of ]]
{{Adams
| number = ML003709436
| issue date = 03/02/1999
| title = Press Release-99-040, Nuclear Regulatory Commission'S Advisory Committee on Medical Use of Isotopes Has Scheduled Meetings March 24-25 in Rockville, Maryland
| author name =
| author affiliation = NRC/OPA
| addressee name =
| addressee affiliation =
| docket =
| license number =
| contact person =
| document report number = Press Release-99-040
| document type = Press Release
| page count = 1
| newsletter region =
| newsletter year = 2099
| newsletter integer = 40
}}
 
=Text=
{{#Wiki_filter:UnitedStatesNuclearRegulatoryCommissionOfficeofPublicAffairsWashington,DC20555Phone301-415-8200Fax301-415-2234 Internet:opa@nrc.govNo.99-40FORIMMEDIATERELEASE(Wednesday,March3,1999)NOTETOEDITORS:TheNuclearRegulatoryCommission'sAdvisoryCommitteeontheMedicalUsesofIsotopeshasscheduledmeetingsMarch24-25inRockville,Maryland.Thecommitteewilldiscussrevisionstotheproposedruleonthemedicaluseofbyproductmaterial,theanalysisofcommentsonthedraftrule,andissuesregardingprostate implanttherapy.Themeetings,whichareopentothepublic,willbeheldintheTwoWhiteFlintAuditorium11545RockvillePike,from9:00a.m.until5:00p.m.thefirstday,andfrom8:00 a.m.untilnoonthesecondday.ThosewishingtoprovideawrittenstatementshouldnotifyMaryLouiseRoe,at301-415-7809.Otheraspectsofthemeeting,includingopportunitiesforquestions,willbe describedinaforthcomingeditionoftheFederalRegister.
###}}

Revision as of 12:12, 14 July 2019

Press Release-99-040, Nuclear Regulatory Commission'S Advisory Committee on Medical Use of Isotopes Has Scheduled Meetings March 24-25 in Rockville, Maryland
ML003709436
Person / Time
Issue date: 03/02/1999
From:
Office of Public Affairs
To:
References
Press Release-99-040
Download: ML003709436 (1)
v • d • e


Text

UnitedStatesNuclearRegulatoryCommissionOfficeofPublicAffairsWashington,DC20555Phone301-415-8200Fax301-415-2234 Internet:opa@nrc.govNo.99-40FORIMMEDIATERELEASE(Wednesday,March3,1999)NOTETOEDITORS:TheNuclearRegulatoryCommission'sAdvisoryCommitteeontheMedicalUsesofIsotopeshasscheduledmeetingsMarch24-25inRockville,Maryland.Thecommitteewilldiscussrevisionstotheproposedruleonthemedicaluseofbyproductmaterial,theanalysisofcommentsonthedraftrule,andissuesregardingprostate implanttherapy.Themeetings,whichareopentothepublic,willbeheldintheTwoWhiteFlintAuditorium11545RockvillePike,from9:00a.m.until5:00p.m.thefirstday,andfrom8:00 a.m.untilnoonthesecondday.ThosewishingtoprovideawrittenstatementshouldnotifyMaryLouiseRoe,at301-415-7809.Otheraspectsofthemeeting,includingopportunitiesforquestions,willbe describedinaforthcomingeditionoftheFederalRegister.

Retrieved from "https://kanterella.com/w/index.php?title=Press_Release-99-040,_Nuclear_Regulatory_Commission%27S_Advisory_Committee_on_Medical_Use_of_Isotopes_Has_Scheduled_Meetings_March_24-25_in_Rockville,_Maryland&oldid=1858069"